Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

In the quiet hours of night, millions of Americans reach for sleeping pills, hoping to find relief from restless thoughts and sleepless nights. While these medications promise the allure of peaceful ...

A new study has linked popular sleeping pills such as Ambien and Restoril with a nearly five-fold increased risk of death. Researchers at Scripps Health, a nonprofit health system in San Diego, ...